SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
31 Januar 2024 - 1:00PM
SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage
biopharmaceutical company focused on severe rare diseases and
cancer, today announced that management will participate in a
fireside chat at the Guggenheim Healthcare Talks 6th Annual
Biotechnology Conference, taking place in New York, New York on
Thursday, February 8, 2024 at 2:00 p.m. ET.
To access the live webcast, please visit the Events
& Presentations page within the Investors & Media section
of the company’s website at https://ir.springworkstx.com. A replay
of the webcast will be available on SpringWorks’ website for a
limited time following the conference.
About SpringWorks Therapeutics
SpringWorks is a commercial-stage biopharmaceutical
company applying a precision medicine approach to developing and
delivering life-changing medicines for people with severe rare
diseases and cancer.
Founded in 2017, SpringWorks has a diversified
targeted oncology pipeline spanning solid tumors and hematological
cancers, including clinical trials in rare tumor types and highly
prevalent, genetically defined cancers. OGSIVEO™, approved in the
United States for the treatment of adult patients with progressing
desmoid tumors who require systemic treatment, is SpringWorks’
first FDA-approved therapy. SpringWorks’ strategic approach and
operational excellence in clinical development have enabled it to
rapidly advance its lead product candidates into late-stage trials
and enter into multiple collaborations with innovators in industry
and academia to unlock the full potential for its portfolio and
create more solutions for patients with cancer.
For more information,
visit www.springworkstx.com and follow @SpringWorksTx on
X (formerly Twitter), LinkedIn, and YouTube.
Contacts:Kim DiamondVice
President, Communications and Investor Relations Phone:
203-561-1646 Email: kdiamond@springworkstx.com
Samantha Hilson Sandler Senior Director,
Investor Relations Phone: 203-461-5501 Email:
samantha.sandler@springworkstx.com
SpringWorks Therapeutics (NASDAQ:SWTX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
SpringWorks Therapeutics (NASDAQ:SWTX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024